Service de radiothérapie, centre Galilée, polyclinique de la Louvière, 69, rue de la Louvière, 59000 Lille, France.

Prostatectomy is one of the most widely used methods for treatment of adenocarcinoma of the prostate. According to anatomopathological criteria, between 10 and 40% of patients will display biochemical relapse in the absence of adjuvant radiotherapy. Anatomopathological and biochemical criteria are powerful tools for selecting patients for salvage radiotherapy. The aim of this article is to review literature on the latest progress in radiological and nuclear medicine techniques and their performance levels, in order to determine local, regional and metastatic relapses associated with the techniques and specify the radiotherapy target volume. Magnetic resonance imaging (MRI) displays the best sensitivity and specificity for examination of the prostate bed and enables simultaneous assessment of the pelvic region - thus diminishing the utility of computed tomography. The performance levels of MRI will probably continue to improve, with the use of dynamic MRI and MR spectroscopy. Despite the development of new markers like (11)C and (18)F choline and acetate, the sensitivity of positron emission tomography is still low. Prospective studies with an appropriate methodology are necessary for specifying the technique's value in this context.

Article in French

Written by:
Pasquier D, Hugentobler A, Masson P.   Are you the author?

Reference:
Cancer Radiother. 2009 Jun;13(3):173-81.
doi:10.1016/j.canrad.2009.02.006

PubMed Abstract
PMID:19414277

UroToday.com Prostate Cancer Section

Please log-in or register in order to submit comments.

Powered by AkoComment!